Market Overview:
The global shrimp disease diagnostics market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for seafood, rising awareness about shrimp diseases and their diagnosis, and growing aquaculture industry. The market is segmented on the basis of type, application, and region. On the basis of type, the global shrimp disease diagnostics market is segmented into white spot syndrome virus (WSSV), thalassemia virus (TSV), yellow head virus/gastroenteritis virus (YHV/GAV), infectious hypodermal and haematopoietic necrosis virus (IHHNV), human papillomavirus (HPV), mycobacterium avium complex (MAC) infection, inclusion body hepatitis-like nephropathy syndrome in Penaeus monodon infected with nodavirus genotype IIIa strain Pn3a_IMNV_NHP-B1(IMNV), Newcastle disease virus (NDV)/velogenic viscerotropic velar Newcastle Disease Virus strain LaSota vaccine viruses expressing green fluorescent protein as a marker gene under control of an El Salvadorian Sindbis viral promoter fragment clone pGEM7Zf(NDVLASOTAVPF) ,and others.
Product Definition:
Shrimp Disease Diagnostics is the process of diagnosing shrimp diseases. This is important because it allows us to determine the cause of the disease and how to treat it.
WSSV:
WSSV is the abbreviation for White Spot Syndrome Virus. It is a virus that affects crustaceans, such as shrimp and crabs. The disease does not affect humans or other vertebrates. WSSV was first identified in 1849 in New York, U.S., and has been spreading ever since then across the globe mainly through imports from the U.S., but also through exports to other countries as well (1).
TSV:
TSV is the most common and widely used method for shrimp disease diagnosis. It is also considered as a standard diagnostic method in many countries. TSV involves tapping the shrimp with a needle to inject serum, which can be done manually or automatically. The number of shrimp that get tapped per sample depends on the volume of sample required for analysis and varies from 1 to 100 depending upon factors such as species, life stage, health status etc.
Application Insights:
Aquaculture laboratories held the largest revenue share of over 60% in 2017. The segment is expected to witness significant growth owing to the rising need for disease diagnosis among various species of aquaculture. Disease outbreaks have a huge impact on the overall profitability and production value of aquafarming activities, which can be measured in terms of both economic as well as sentimental terms. Therefore, it is important for farmers to conduct regular health checkups on their stock and also make necessary arrangements in case if any outbreak occurs during farming activities.
The education & research sector accounted for 19% revenue share in 2017 due to presence of numerous institutes involved with shrimp-related studies across the globe such as Centers for Disease Control and Prevention (CDC), state agencies, universities/ colleges, private institutions.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its position during the forecast period due to presence of developed aquaculture industry and advanced diagnostic technologies. Asia Pacific is projected to grow at a lucrative CAGR over the forecast period owing to increasing awareness among people about seafood consumption, rising demand for high-quality seafood products, and expansion of aquaculture facilities in countries such as China, India, Indonesia & Thailand. Moreover, government initiatives encouraging private investments are likely to boost regional growth over the next eight years.
Growth Factors:
- Increasing demand for seafood, especially shrimp, is driving the growth of the shrimp disease diagnostics market.
- The increasing prevalence of diseases in shrimp populations is fueling the demand for shrimp disease diagnostics products and services.
- The growing awareness about the benefits of using shrimp disease diagnostics products and services is contributing to the growth of this market.
- The increasing number of research studies on shrimp diseases is providing a boost to the development of new diagnostic technologies and products that can help in early detection and treatment of these diseases. 5) Technological advancements are leading to innovative diagnostic methods that are helping in accurate diagnosis and treatment of various typesof shrimppathogens, thus propellingthegrowthoftheshrimpdiseasediagnosticsmarket
Scope Of The Report
Report Attributes
Report Details
Report Title
Shrimp Disease Diagnostics Market Research Report
By Type
WSSV, TSV, YHV/GAV, IHHNV, HPV, MBV, IMNV, NHP-B, MoV, Others
By Application
Fisheries, Aquaculture Laboratories, Marine Laboratories, Education and Research Institutes, Others
By Companies
HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, SUREBIO, Auro Biotechnologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
158
Number of Tables & Figures
111
Customization Available
Yes, the report can be customized as per your need.
Global Shrimp Disease Diagnostics Market Report Segments:
The global Shrimp Disease Diagnostics market is segmented on the basis of:
Types
WSSV, TSV, YHV/GAV, IHHNV, HPV, MBV, IMNV, NHP-B, MoV, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Fisheries, Aquaculture Laboratories, Marine Laboratories, Education and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- HiMedia Laboratories
- Speedy Assay Sdn Bhd
- REAGEN LLC
- FUJIKURA KASEI CO., LTD.
- GeneReach Biotechnology Corp
- Thermo Fisher Scientific
- Lab - Ind Resource Sdn Bhd
- SUREBIO
- Auro Biotechnologies
Highlights of The Shrimp Disease Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- WSSV
- TSV
- YHV/GAV
- IHHNV
- HPV
- MBV
- IMNV
- NHP-B
- MoV
- Others
- By Application:
- Fisheries
- Aquaculture Laboratories
- Marine Laboratories
- Education and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Shrimp Disease Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Shrimp Disease Diagnostics is a company that provides diagnostic services for shrimp diseases. These services include the detection and identification of shrimp diseases, as well as the development of treatment plans.
Some of the major players in the shrimp disease diagnostics market are HiMedia Laboratories, Speedy Assay Sdn Bhd, REAGEN LLC, FUJIKURA KASEI CO., LTD., GeneReach Biotechnology Corp, Thermo Fisher Scientific, Lab - Ind Resource Sdn Bhd, SUREBIO, Auro Biotechnologies.
The shrimp disease diagnostics market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Shrimp Disease Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Shrimp Disease Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Shrimp Disease Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Shrimp Disease Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Shrimp Disease Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Shrimp Disease Diagnostics Market Size and Y-o-Y Growth
4.5.2 Shrimp Disease Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Shrimp Disease Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Shrimp Disease Diagnostics Market Size Forecast by Type
5.2.1 WSSV
5.2.2 TSV
5.2.3 YHV/GAV
5.2.4 IHHNV
5.2.5 HPV
5.2.6 MBV
5.2.7 IMNV
5.2.8 NHP-B
5.2.9 MoV
5.2.10 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Shrimp Disease Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Shrimp Disease Diagnostics Market Size Forecast by Applications
6.2.1 Fisheries
6.2.2 Aquaculture Laboratories
6.2.3 Marine Laboratories
6.2.4 Education and Research Institutes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Shrimp Disease Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Shrimp Disease Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Shrimp Disease Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Shrimp Disease Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Shrimp Disease Diagnostics Market Size Forecast by Type
9.6.1 WSSV
9.6.2 TSV
9.6.3 YHV/GAV
9.6.4 IHHNV
9.6.5 HPV
9.6.6 MBV
9.6.7 IMNV
9.6.8 NHP-B
9.6.9 MoV
9.6.10 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Shrimp Disease Diagnostics Market Size Forecast by Applications
9.10.1 Fisheries
9.10.2 Aquaculture Laboratories
9.10.3 Marine Laboratories
9.10.4 Education and Research Institutes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Shrimp Disease Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Shrimp Disease Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Shrimp Disease Diagnostics Market Size Forecast by Type
10.6.1 WSSV
10.6.2 TSV
10.6.3 YHV/GAV
10.6.4 IHHNV
10.6.5 HPV
10.6.6 MBV
10.6.7 IMNV
10.6.8 NHP-B
10.6.9 MoV
10.6.10 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Shrimp Disease Diagnostics Market Size Forecast by Applications
10.10.1 Fisheries
10.10.2 Aquaculture Laboratories
10.10.3 Marine Laboratories
10.10.4 Education and Research Institutes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Shrimp Disease Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Shrimp Disease Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Shrimp Disease Diagnostics Market Size Forecast by Type
11.6.1 WSSV
11.6.2 TSV
11.6.3 YHV/GAV
11.6.4 IHHNV
11.6.5 HPV
11.6.6 MBV
11.6.7 IMNV
11.6.8 NHP-B
11.6.9 MoV
11.6.10 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Shrimp Disease Diagnostics Market Size Forecast by Applications
11.10.1 Fisheries
11.10.2 Aquaculture Laboratories
11.10.3 Marine Laboratories
11.10.4 Education and Research Institutes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Shrimp Disease Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Shrimp Disease Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Shrimp Disease Diagnostics Market Size Forecast by Type
12.6.1 WSSV
12.6.2 TSV
12.6.3 YHV/GAV
12.6.4 IHHNV
12.6.5 HPV
12.6.6 MBV
12.6.7 IMNV
12.6.8 NHP-B
12.6.9 MoV
12.6.10 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Shrimp Disease Diagnostics Market Size Forecast by Applications
12.10.1 Fisheries
12.10.2 Aquaculture Laboratories
12.10.3 Marine Laboratories
12.10.4 Education and Research Institutes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Shrimp Disease Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Shrimp Disease Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Shrimp Disease Diagnostics Market Size Forecast by Type
13.6.1 WSSV
13.6.2 TSV
13.6.3 YHV/GAV
13.6.4 IHHNV
13.6.5 HPV
13.6.6 MBV
13.6.7 IMNV
13.6.8 NHP-B
13.6.9 MoV
13.6.10 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Shrimp Disease Diagnostics Market Size Forecast by Applications
13.10.1 Fisheries
13.10.2 Aquaculture Laboratories
13.10.3 Marine Laboratories
13.10.4 Education and Research Institutes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Shrimp Disease Diagnostics Market: Competitive Dashboard
14.2 Global Shrimp Disease Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 HiMedia Laboratories
14.3.2 Speedy Assay Sdn Bhd
14.3.3 REAGEN LLC
14.3.4 FUJIKURA KASEI CO., LTD.
14.3.5 GeneReach Biotechnology Corp
14.3.6 Thermo Fisher Scientific
14.3.7 Lab - Ind Resource Sdn Bhd
14.3.8 SUREBIO
14.3.9 Auro Biotechnologies
